Jane Xia is an Assistant General Counsel Patents at Johnson & Johnson, specializing in patent strategy, portfolio development, licensing, and IP-related transactions. With over 13 years of experience, she has supported the full lifecycle of pharmaceutical development—from early discovery through clinical stages—playing a key role in protecting the company's innovative assets across multiple therapeutic areas.